Next Article in Journal
Neural Predictors of the Antidepressant Placebo Response
Previous Article in Journal
C3orf70 Is Involved in Neural and Neurobehavioral Development
Previous Article in Special Issue
Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go
Open AccessReview

Computer-Assisted and Data Driven Approaches for Surveillance, Drug Discovery, and Vaccine Design for the Zika Virus

1
Department of Chemistry and Biochemistry, University of Minnesota, Duluth, MN 55812, USA
2
University of Florida Informatics Institute, Gainesville, FL 32601, USA
3
Centre for Interdisciplinary Research and Education, Kolkata 700068, India
4
National Institute of Chemistry, Hajdrihova 19, Ljubljana 1000, Slovenia
5
Biomedical Graduate Research Organization, Department of Microbiology and Immunology School of Medicine, Georgetown University, Washington, DC 20057, USA
*
Author to whom correspondence should be addressed.
Currently in AT&T Labs Research.
Pharmaceuticals 2019, 12(4), 157; https://doi.org/10.3390/ph12040157
Received: 24 September 2019 / Revised: 14 October 2019 / Accepted: 15 October 2019 / Published: 16 October 2019
(This article belongs to the Special Issue Zika Virus: Therapeutic Advances)
Human life has been at the edge of catastrophe for millennia due diseases which emerge and reemerge at random. The recent outbreak of the Zika virus (ZIKV) is one such menace that shook the global public health community abruptly. Modern technologies, including computational tools as well as experimental approaches, need to be harnessed fast and effectively in a coordinated manner in order to properly address such challenges. In this paper, based on our earlier research, we have proposed a four-pronged approach to tackle the emerging pathogens like ZIKV: (a) Epidemiological modelling of spread mechanisms of ZIKV; (b) assessment of the public health risk of newly emerging strains of the pathogens by comparing them with existing strains/pathogens using fast computational sequence comparison methods; (c) implementation of vaccine design methods in order to produce a set of probable peptide vaccine candidates for quick synthesis/production and testing in the laboratory; and (d) designing of novel therapeutic molecules and their laboratory testing as well as validation of new drugs or repurposing of drugs for use against ZIKV. For each of these stages, we provide an extensive review of the technical challenges and current state-of-the-art. Further, we outline the future areas of research and discuss how they can work together to proactively combat ZIKV or future emerging pathogens. View Full-Text
Keywords: viral epidemics; Zika virus (ZIKV); SIR models; 2D graphical method; peptide vaccine design; mahalanobis distance; principal component analysis (PCA); neighborhood matrix; computer-assisted anti-Zika drug discovery viral epidemics; Zika virus (ZIKV); SIR models; 2D graphical method; peptide vaccine design; mahalanobis distance; principal component analysis (PCA); neighborhood matrix; computer-assisted anti-Zika drug discovery
Show Figures

Graphical abstract

MDPI and ACS Style

Basak, S.C.; Majumdar, S.; Nandy, A.; Roy, P.; Dutta, T.; Vracko, M.; Bhattacharjee, A.K. Computer-Assisted and Data Driven Approaches for Surveillance, Drug Discovery, and Vaccine Design for the Zika Virus. Pharmaceuticals 2019, 12, 157.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop